venBio Partners LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001776382 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value: $451M (100.0% shares, 0.0% debt)

Holdings (10)

ALXO ALX ONCOLOGY HLDGS INC 36.3%

Value $164M Shares 9,699,925 Est. Cost $39.31 Unrealized -56.6%

HRMY HARMONY BIOSCIENCES HLDGS IN 16.7%

Value $75.14M Shares 1,544,484 Est. Cost $36.46 Unrealized +11.9%

VTYX VENTYX BIOSCIENCES INC 15.1%

Value $68.01M Shares 5,011,536 Est. Cost $18.95 Unrealized -29.5%

PHVS PHARVARIS N V 9.3%

Value $41.77M Shares 2,303,310 Est. Cost $31.46 Unrealized -44.1%

— CINCOR PHARMA INC 7.7%

Value $34.74M Shares 1,980,706 Est. Cost $17.54 Unrealized —

— AKERO THERAPEUTICS INC 6.8%

Value $30.82M Shares 2,171,664 Est. Cost $19.15 Unrealized —

— IMPEL NEUROPHARMA INC 3.9%

Value $17.58M Shares 2,759,791 Est. Cost $8.85 Unrealized —

— CHECKMATE PHARMACEUTICALS IN 2.6%

Value $11.72M Shares 3,673,374 Est. Cost $11.51 Unrealized —

— ELEVATION ONCOLOGY INC 1.5%

Value $6.573M Shares 2,608,167 Est. Cost $13.57 Unrealized —

— VERONA PHARMA PLC 0.2%

Value $808K Shares 161,897 Est. Cost $9.65 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ALXO	ALX ONCOLOGY HLDGS INC	9,699,925	$164M	36.3%	$39.31	-56.6%	COM	00166B105
HRMY	HARMONY BIOSCIENCES HLDGS IN	1,544,484	$75.14M	16.7%	$36.46	+11.9%	COM	413197104
VTYX	VENTYX BIOSCIENCES INC	5,011,536	$68.01M	15.1%	$18.95	-29.5%	COM	92332V107
PHVS	PHARVARIS N V	2,303,310	$41.77M	9.3%	$31.46	-44.1%	COM	N69605108
—	CINCOR PHARMA INC	1,980,706	$34.74M	7.7%	$17.54	—	COM	17240Y109
—	AKERO THERAPEUTICS INC	2,171,664	$30.82M	6.8%	$19.15	—	COM	00973Y108
—	IMPEL NEUROPHARMA INC	2,759,791	$17.58M	3.9%	$8.85	—	COM	45258K109
—	CHECKMATE PHARMACEUTICALS IN	3,673,374	$11.72M	2.6%	$11.51	—	COM	162818108
—	ELEVATION ONCOLOGY INC	2,608,167	$6.573M	1.5%	$13.57	—	COM	28623U101
—	VERONA PHARMA PLC	161,897	$808K	0.2%	$9.65	—	SPONSORED ADS	925050106